Estie Mermelstein, MSN, FNP-BC

Estie Mermelstein, MSN, FNP-BC, earned her Master of Science in nursing from Columbia University School of Nursing. She has worked as a nurse in women’s health and as a nurse practitioner in family medicine. Estie also earned a Bachelor of Arts in journalism and was editor-in-chief of her undergraduate newspaper. She currently freelances in medical communications with a focus on clinician-facing content. She and her husband have three young children and live in New Jersey.

All articles by Estie Mermelstein, MSN, FNP-BC

Pneumonia

Patients With CAP At Increased Risk of CV Events and Poor Clinical Outcomes

Estie Mermelstein, MSN, FNP-BC

April 12, 2021

Investigators assessed the cumulative incidence of acute cardiovascular complications during hospitalization for community-acquired pneumonia in internal medicine units.

General Infectious Disease

New Biomarkers Predict Mortality, Clinical Features of Infective Endocarditis

Estie Mermelstein, MSN, FNP-BC

April 2, 2021

Researchers analyzed data from patients with a recent diagnosis of IE hospitalized to see whether PCT, proADM, and copeptin have prognostic value in IE compared with CRP, a known biomarker for IE.

Vector-borne Illnesses

Zika Virus Transmission Correlated with Risky Sexual Behavior in Men

Estie Mermelstein, MSN, FNP-BC

April 1, 2021

Researchers used a retrospective survey to associate sexual behavior during the Zika virus epidemic to better understand the disease burden of sexually transmitted Zika virus.

Hepatitis

SOF/VEL Safe and Effective for HCV Patients With Severe Renal Disease

Estie Mermelstein, MSN, FNP-BC

March 31, 2021

The researchers wanted to collect data about the real-world effectiveness and safety of SOF/VEL in patients with chronic HCV infection and severe renal impairment.

General Infectious Disease

Fluoroquinolones Associated With Increased Aortic Aneurysm Risk

Estie Mermelstein, MSN, FNP-BC

March 22, 2021

Study authors assessed aortic aneurysm and dissection risks after fluoroquinolone use in the United States.

Hepatitis

High Prevalence of HCV Infection in MSM Regardless of HIV Status

Estie Mermelstein, MSN, FNP-BC

March 11, 2021

The researchers’ objective was to determine the prevalence of HCV antibodies among MSM with and without HIV, as well as factors associated with HCV infection among MSM.

HIV/AIDS

Prophylactic Effects of Dolutegravir in Infants With HIV Transmission Risk

Estie Mermelstein, MSN, FNP-BC

March 4, 2021

Investigators used data from mothers and infants enrolled in the DolPHIN-1 trial to develop a population pharmacokinetic model of dolutegravir.

General Infectious Disease

Mucocutaneous Symptoms of Multisystem Inflammatory Syndrome in Pediatric Patients

Estie Mermelstein, MSN, FNP-BC

March 2, 2021

The mucocutaneous features seen in hospitalized children with MIS-C and how these findings are associated with the onset of systemic symptoms are characterized.

COVID19

JAK-inhibitor and Type I Interferon Possible Treatments for COVID-19

Estie Mermelstein, MSN, FNP-BC

February 23, 2021

Study authors conducted a systematic review and meta-analysis to assess the efficacy of Janus kinase-inhibitors and Type I interferons as potential antiviral candidates for the treatment of COVID-19.

Antibiotics, Antimicrobial Resistance

Healthy Microbiome Is Key to Sepsis Management

Estie Mermelstein, MSN, FNP-BC

February 23, 2021

The authors emphasize that sepsis treatment should be guided by the connection between the microbiota and sepsis outcomes.

Next post in Antibiotics, Antimicrobial Resistance